Is a bilirubin level of 1.1 considered normal for an adult or newborn patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bilirubin 1.1 mg/dL: Normal in Adults, Requires Context-Specific Evaluation in Newborns

A bilirubin level of 1.1 mg/dL is normal in adults but requires age-specific interpretation in newborns using hour-specific nomograms, as this level may be normal, low-risk, or concerning depending on the infant's age in hours and risk factors. 1

For Adult Patients

  • A total bilirubin of 1.1 mg/dL falls within the normal reference range for adults and does not require intervention or further evaluation in the absence of other clinical concerns. 2

  • The 99th percentile for normal bilirubin in healthy adults is well above this level, making 1.1 mg/dL clearly within normal limits. 3

  • If this represents a change from baseline or occurs with other liver function abnormalities, fractionated bilirubin (direct/indirect) and complete liver function tests (ALT, AST, ALP, albumin) should be obtained to assess for underlying hepatobiliary disease. 2

For Newborn Patients (≥35 Weeks Gestation)

Age-Specific Interpretation is Critical

  • All bilirubin levels in newborns must be interpreted according to the infant's age in hours, not days, using the Bhutani nomogram to determine risk zone (low, intermediate, high). 1

  • A total serum bilirubin (TSB) of 1.1 mg/dL in a newborn could fall anywhere from the low-risk to high-risk zone depending on whether the infant is 12 hours old versus 48 hours old. 1

  • Visual estimation of jaundice is unreliable, particularly in darkly pigmented infants—laboratory measurement is essential for accurate assessment. 1, 4

When 1.1 mg/dL is Concerning in Newborns

  • If the direct (conjugated) bilirubin is >1.0 mg/dL when total bilirubin is ≤5 mg/dL (including 1.1 mg/dL), this is abnormal and requires urgent evaluation for cholestasis. 4, 5, 3

  • Jaundice appearing in the first 24 hours of life is always pathologic regardless of the absolute bilirubin level and requires immediate measurement of TSB and evaluation for hemolytic disease. 1, 6

  • Any conjugated bilirubin >25 μmol/L (approximately 1.5 mg/dL) requires urgent referral to evaluate for biliary atresia or other cholestatic diseases. 5

Risk Stratification for Newborns

  • Obtain fractionated bilirubin to determine the direct/indirect components if there is any clinical concern. 4, 2

  • Major risk factors that lower the threshold for concern include: blood group incompatibility with positive Coombs test, G6PD deficiency, gestational age 35-36 weeks, cephalohematoma, exclusive breastfeeding with poor intake, and East Asian race. 1

  • The predischarge TSB level plotted on the hour-specific nomogram is the best documented method for predicting risk of subsequent severe hyperbilirubinemia. 1

Follow-Up Recommendations

  • All newborns should have risk assessment before discharge, particularly those discharged before 72 hours of age. 1

  • If TSB is in the low-risk zone on the nomogram, the infant is at very low risk for developing severe hyperbilirubinemia. 1

  • Jaundice persisting beyond 3 weeks of age requires measurement of total and direct bilirubin to identify potential cholestasis, regardless of the absolute level. 1, 4

Key Clinical Pitfalls to Avoid

  • Never subtract direct bilirubin from total bilirubin when making treatment decisions—always use the total bilirubin level for phototherapy and exchange transfusion thresholds. 4, 2, 5

  • Do not rely on visual assessment of jaundice severity—this leads to errors, especially in infants with darker skin pigmentation. 1

  • In newborns, failure to use hour-specific interpretation can result in either unnecessary intervention or dangerous delays in treatment. 1

  • Standard laboratory tests for hemolysis (reticulocyte count, haptoglobin) have poor sensitivity and specificity in newborns. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Elevated Total Bilirubin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Interpreting conjugated bilirubin levels in newborns.

The Journal of pediatrics, 2011

Guideline

Assessment and Management of Hyperbilirubinemia in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Elevated Gamma-GT in Neonates with Normal Direct Bilirubin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyperbilirubinemia in the term newborn.

American family physician, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.